Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Inhibitors of selectin binding and cell adhesion prepared at Nippon Shinyaku

March 17, 1998

Favorable results obtained with Enbrel combination in RA

March 16, 1998

Procter & Gamble reports novel NSAIDs with improved GI safety

March 16, 1998

Celgene expands phase I trial of TNF-alpha inhibitor

March 16, 1998

A new hypothesis may explain the high incidence of autoimmune disorders in women

March 13, 1998

P&U scientists disclose new MMP inhibitors for connective tissue diseases

March 12, 1998

Biomatrix and Novartis sign distribution agreement for Synvisc

March 11, 1998

New indication for Mobic cleared by U.K. authorities

March 6, 1998

AnervaX peptide vaccine successfully completes phase IIa trial

March 6, 1998

Arthritis Advisory Committee meets later this month

March 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...